These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 6470486

  • 1. Species-restricted target cell lysis by human complement: complement-lysed erythrocytes from heterologous and homologous species differ in their ratio of bound to inserted C9.
    Hu VW, Shin ML.
    J Immunol; 1984 Oct; 133(4):2133-7. PubMed ID: 6470486
    [Abstract] [Full Text] [Related]

  • 2. Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9.
    Shin ML, Hänsch G, Hu VW, Nicholson-Weller A.
    J Immunol; 1986 Mar 01; 136(5):1777-82. PubMed ID: 2419414
    [Abstract] [Full Text] [Related]

  • 3. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore.
    Bhakdi S, Tranum-Jensen J.
    J Immunol; 1986 Apr 15; 136(8):2999-3005. PubMed ID: 3958488
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9.
    Tomlinson S, Whitlow MB, Nussenzweig V.
    J Immunol; 1994 Feb 15; 152(4):1927-34. PubMed ID: 7509832
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell.
    Hänsch GM, Hammer CH, Mayer MM, Shin ML.
    J Immunol; 1981 Sep 15; 127(3):999-1002. PubMed ID: 6911149
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Restriction of cell lysis by homologous complement: I. An analysis of membrane attack complex formation on target membranes.
    Houle JJ, Hoffmann EM, Esser AF.
    Blood; 1988 Feb 15; 71(2):280-6. PubMed ID: 3337896
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. On the mechanism of cell membrane damage by complement: evidence on insertion of polypeptide chains from C8 and C9 into the lipid bilayer of erythrocytes.
    Hammer CH, Shin ML, Abramovitz AS, Mayer MM.
    J Immunol; 1977 Jul 15; 119(1):1-8. PubMed ID: 559700
    [Abstract] [Full Text] [Related]

  • 16. On the cause and nature of C9-related heterogeneity of terminal complement complexes generated on target erythrocytes through the action of whole serum.
    Bhakdi S, Tranum-Jensen J.
    J Immunol; 1984 Sep 15; 133(3):1453-63. PubMed ID: 6747293
    [Abstract] [Full Text] [Related]

  • 17. Complement lysis: evidence for an amphiphilic nature of the terminal membrane C5b-9 complex of human complement.
    Bhakdi S, Bjerrum OJ, Bhakdi-Lehnen B, Tranum-Jensen J.
    J Immunol; 1978 Dec 15; 121(6):2526-32. PubMed ID: 569173
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Membrane vesiculation protects erythrocytes from destruction by complement.
    Iida K, Whitlow MB, Nussenzweig V.
    J Immunol; 1991 Oct 15; 147(8):2638-42. PubMed ID: 1918984
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.